Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,591.89 75.62 0.52%
TOPIX 1,178.34 4.97 0.42%
HANG SENG 22,760.24 64.23 0.28%

Girard Gibbs LLP Partner Eric Gibbs Appointed to Plaintiffs’ Steering Committee for Coordinated California GranuFlo/NaturaLyte



  Girard Gibbs LLP Partner Eric Gibbs Appointed to Plaintiffs’ Steering
  Committee for Coordinated California GranuFlo/NaturaLyte Lawsuit

   Eric Gibbs of Girard Gibbs LLP was appointed to the Plaintiffs’ Steering
         Committee in the consolidated GranuFlo/NaturaLyte litigation

Business Wire

SAN FRANCISCO -- July 31, 2013

The law firm of Girard Gibbs LLP is pleased to announce that Eric Gibbs, a
partner with the firm, has been appointed to the Plaintiffs’ Steering
Committee for the prosecution of the GranuFlo/NaturaLyte Cases (JCCP 4749).
The GranuFlo lawsuits are coordinated in the Superior Court of California,
County of Los Angeles.

On July 19, 2013, the Honorable Lee Smalley Edmon appointed Mr. Gibbs to the
Plaintiffs’ Steering Committee, which will be responsible for managing and
conducting California state court litigation on behalf of all plaintiffs in
the consolidated GranuFlo/NaturaLyte lawsuits.

“It is a privilege to be able to work alongside this group of respected
attorneys and represent the individuals and their loved ones who have been
harmed by GranuFlo and NaturaLyte,” said Mr. Gibbs, whose practice is devoted
to prosecuting large-scale class, mass and collective actions. “I believe that
with our combined experience and expertise, we will be able to show that
Fresenius Medical Care knew of the dangers linked to GranuFlo and NaturaLyte
and nonetheless did not adequately disclose these risks,” stated Mr. Gibbs.

GranuFlo and NaturaLyte are products used in hemodialysis to treat acute and
chronic renal failure. GranuFlo was first approved in 2003 by the Food and
Drug Administration (FDA) for sale in the U.S. However, in March 2012, the FDA
issued a safety alert on GranuFlo and NaturaLyte after the agency received
information about the apparent link between the drugs and cardiovascular
events, such as cardiac arrest, death, and other injuries. In June 2012, the
FDA issued a Class 1 recall of GranuFlo and NaturaLyte, the most serious class
of recall. More than fifteen lawsuits have been filed in California superior
courts against manufacturer Fresenius and the number continues to grow.

About Girard Gibbs LLP

Girard Gibbs LLP is a national litigation firm based in San Francisco and New
York representing plaintiffs in class and collective actions in state and
federal courts, and in arbitration matters worldwide. The firm serves
individuals, institutions and business clients in cases involving personal
injury mass tort, consumer protection, securities, antitrust, and employment
laws. Girard Gibbs was distinguished as a Tier 1 law firm for plaintiffs’ mass
tort and class-action litigation in the 2013 “Best Law Firms” list, an annual
survey published in the U.S. News & World Report’s Money Issue. The National
Law Journal (NLJ) named Girard Gibbs to its elite “Plaintiffs’ Hot List” for
2012, a selection of top U.S. plaintiffs’ firms recognized for wins in
high-profile cases.

Contact:

Girard Gibbs LLP
Dylan Hughes, 415-981-4800
dsh@girardgibbs.com
Lindsey Qualman, 415-981-4800
ljq@girardgibbs.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement